University of the Pacific
 

Location

Room R103 in The Rotunda, School of Pharmacy and Health Sciences, University of the Pacific, Stockton campus

Start Date

4-4-2017 12:00 PM

End Date

4-4-2017 1:00 PM

Description

Esfandiearei will be discussing her research on understanding the underlying mechanisms contributing to the progression of aortic aneurysm in Marfan syndrome and the protective effects that exercise may have on the disease process in both laboratory animal models and human patients. Her research has been supported by the Canadian Institutes of Health Research (CIHR), Rare Diseases Foundation, and the Marfan Foundation.

Presenter Bio

Mitra Esfandiarei PhD, assistant professor of biomedical sciences at Midwestern University in Arizona, will be the speaker for the April Science Seminar Series lecture.

Esfandiarei is also an adjunct professor of pharmacology and therapeutics at the University of British Columbia in Vancouver, Canada. She has obtained her BSc in Microbiology with high distinction from Tehran University, a Masters in Medical Microbiology from Razi Vaccine and Serum Research Institute in Iran, and a PhD in Pathology and Laboratory Medicine from the University of British Columbia, Canada. She then finished a postdoctoral fellowship in pharmacology at the Child and Family Research Institute before taking her position at Midwestern University.

Click here to view the presenter's profile page

Host

Roshanak Rahimian

Share

COinS
 
Apr 4th, 12:00 PM Apr 4th, 1:00 PM

Exploring therapeutic approaches for Marfan syndrome associated aortic aneurysm

Room R103 in The Rotunda, School of Pharmacy and Health Sciences, University of the Pacific, Stockton campus

Esfandiearei will be discussing her research on understanding the underlying mechanisms contributing to the progression of aortic aneurysm in Marfan syndrome and the protective effects that exercise may have on the disease process in both laboratory animal models and human patients. Her research has been supported by the Canadian Institutes of Health Research (CIHR), Rare Diseases Foundation, and the Marfan Foundation.